| Bioactivity | (R)-BRD3731 is a GSK3 inhibitor extracted from patent US20160375006A1, compound example 273, has IC50s of 1.05 and 6.7 μM for GSK3β and GSK3α, respectively[1]. | ||||||||||||
| Name | (R)-BRD3731 | ||||||||||||
| CAS | 2056262-08-7 | ||||||||||||
| Formula | C24H31N3O | ||||||||||||
| Molar Mass | 377.52 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Scolnick E, et, al. Uses of paralog-selective inhibitors of gsk3 kinases. US20160375006A1. |
(R)-BRD3731
CAS: 2056262-08-7 F: C24H31N3O W: 377.52
(R)-BRD3731 is a GSK3 inhibitor extracted from patent US20160375006A1, compound example 273, has IC50s of 1.05 and 6.7
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.